Status:
RECRUITING
Non Invasive Measurement With Trans Cranial Doppler Versus Invasive Measurement in Pediatric Age
Lead Sponsor:
Azienda Ospedaliera di Padova
Conditions:
Intracranial Hypertension
Eligibility:
All Genders
Up to 18 years
Brief Summary
An increase of intracranial pressure (ICP) is an important cause of secondary brain damage. The gold standard for measuring ICP is represented by invasive positioning of intracranial ICP devices. The...
Detailed Description
An iIncrease in intracranial pressure (ICP) is an important cause of secondary brain damage. The cerebral perfusion pressure (CPP), defined as the mean arterial pressure value (MAP) minus the ICP valu...
Eligibility Criteria
Inclusion
- invasive ICP placement
Exclusion
- cranial base fracture
- absent informed consent
Key Trial Info
Start Date :
July 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT05340062
Start Date
July 1 2022
End Date
December 31 2025
Last Update
January 28 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
PICU IRCSS Sant'Orsola Malpighi
Bologna, Italy
2
PICU Spedali Civili BRescia
Brescia, Italy
3
PICU Ospedale Mayer
Florence, Italy
4
PICU Ospedale Gaslini
Genova, Italy